Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 09 Jul 2026 for Syndax Pharmaceuticals Inc, €181k. Read the official filing
Filing timeline
BuySaleMichael A. Metzger
Insider track record
Disclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Michael A. Metzger: trading record in brief
Michael A. Metzger (chief executive) discloses dealings in 2 companies, chiefly Syndax Pharmaceuticals Inc and CTI Biopharma Corp. Between 13 September 2021 and 8 July 2026, the trades on record add up to 25 filings.
No open-market purchase appears, only 5 sales worth €1.3M. Besides market trades, the filings include 3 share grants and 17 option exercises. In 2026 alone, the filings show no purchases and 2 sales.
The latest filing, published on 9 July 2026, reports an open-market sale of €688k in Syndax Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael A. Metzger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
32,375 shares@ US$6.380.0095% mcap10.5% of flowCommon StockSEC:0001193125-26-299803:0
32,375 shares@ US$24.24020.036% mcap39.7% of flowCommon StockSEC:0001193125-26-299803:1
17,159 shares@ US$21.02811.0% of flowCommon StockSEC:0001193125-26-043814:0
73,000 shares0Common StockSEC:0001193125-26-041500:0
157,307 shares@ US$10.9058.9% of flowCommon StockSEC:0000950170-25-113659:0
7,534 shares@ US$9.2855.9% of flowCommon StockSEC:0000950170-25-096947:0
6,074 shares@ US$7.204.2% of flowCommon StockSEC:0000950170-25-039787:0
7,814 shares@ US$7.205.6% of flowCommon StockSEC:0000950170-25-034634:0
13,288 shares@ US$15.50420.9% of flowCommon StockSEC:0000950170-25-019000:0
60,500 shares0Common StockSEC:0000950170-25-016384:0
107,250 shares0Common StockSEC:0001562180-24-001223:0
5,959 shares@ US$6.383.7% of flowCommon StockSEC:0001562180-23-001118:0
28,500 shares@ US$0.841115.3% of flowcommon stockSEC:0000891293-22-000055:0
16,231 shares@ US$8.7715.2% of flowCommon StockSEC:0001562180-22-007124:0
29,606 shares@ US$8.7727.6% of flowCommon StockSEC:0001562180-22-007012:0
19,764 shares@ US$6.3812.9% of flowCommon StockSEC:0001562180-22-005761:0
9,000 shares@ US$6.5036.8% of flowcommon stockSEC:0000891293-22-000036:0
15,009 shares@ US$6.389.8% of flowCommon StockSEC:0001562180-22-005637:0
91,500 shares@ US$0.841147.9% of flowcommon stockSEC:0000891293-22-000035:0
22,715 shares@ US$6.387.4% of flowCommon StockSEC:0001562180-21-007809:0
2,045 shares@ US$7.200.8% of flowCommon StockSEC:0001562180-21-007710:0
44,704 shares@ US$7.2016.0% of flowCommon StockSEC:0001562180-21-006652:0
24,437 shares@ US$7.208.7% of flowCommon StockSEC:0001562180-21-006136:0
31,455 shares@ US$7.2011.1% of flowCommon StockSEC:0001562180-21-006060:0
16,651 shares@ US$7.205.9% of flowCommon StockSEC:0001562180-21-005948:0
25 of 25 declarations
